Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial-Reference-Cited by-同舟云学术

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

Published:2011-02 Issue:2 Volume:12 Page:153-159
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Lorch Jochen H,Goloubeva Olga,Haddad Robert I,Cullen Kevin,Sarlis Nicholas,Tishler Roy,Tan Ming,Fasciano John,Sammartino Daniel E,Posner Marshall R

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer;Adelstein;J Clin Oncol,2003

3. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma;Denis;J Clin Oncol,2004

4. Recent advances in head and neck cancer;Haddad;N Engl J Med,2008

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers and hotspots in induction chemotherapy of oral squamous cell carcinoma: a bibliometric and visualized study from 2000 to 2022 by Bioinformatics and Cancer Database Analysis;2024-08-13

2. Neoadjuvant chemotherapy followed by transoral robotic surgery versus upfront surgery for locoregionally advanced oropharyngeal carcinoma: A propensity score matched analysis;Head & Neck;2024-08

3. Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial;Nature Communications;2024-06-19

4. Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma;Cell Reports Medicine;2024-06

5. Evaluation of response to neoadjuvant chemotherapy in technically unresectable moderately advanced oral cavity cancers;Journal of Cancer Research and Therapeutics;2024-04